Breast cancer, according to doctors, is the most common cancer in women in India, accounting for 41% of cases in women in urban regions and the second most common in rural regions. The average age of women diagnosed with breast cancer has decreased from 40–70 years to 30–50 years.
Breast cancer screening is the process of examining a woman’s breasts for cancer before she exhibits any signs or symptoms of the disease. While breast cancer screening cannot prevent the disease, it detects breast cancer abnormalities at the earliest. Early detection ensures affordable and effective treatment options and a higher survival rate of greater than 90%. Some of the common early breast cancer screening tests include mammograms, breast ultrasounds, breast imaging tests, breast MRIs, and clinical breast exams.
MedPiper Technologies and JournoMed in collaboration with Niramai, are conducting a webinar titled “Early Detection of Breast Cancer, Screening Modalities and Treatment” which will explore the workings and roles of various breast cancer screening methods.
The event will be held on 8th April, 2022, Friday at 5 pm. Participants can join by registering for it here. For more details, participants may contact Soumya T.S at firstname.lastname@example.org/9080078447. E-Certificates will be provided to all the participants.
Dr. Lakshmi Krishnan, Senior Clinical Research Scientist, Niramai Health Analytix
Dr. R. Suresh Kumar, Radiation Oncologist, Clinical Director and CEO – Banglaore Cancer Centre Consultant – Erode Cancer Centre
Breast cancer is mostly discovered after symptoms occur, although many people with breast cancer have little or no symptoms. This further emphasizes the need to get screened for breast cancer on a frequent basis to reduce metastasis. Determining breast cancer risks is vital for building an effective treatment plan. This webinar will also go over different breast cancer therapy choices.
Update: The post event summary of the webinar is available to read here.